Request Deal Involvement
Syngene to acquire Baltimore-Bayview facility from Emergent BioSolutions for $36.5m.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
financial advisors
Truist Securities
legal advisors
Covington & Burling
or
Principals
target
EMERGENT BIOSOLUTIONS (BALTIMORE-BAYVIEW FACILITY)
vendor
EMERGENT BIOSOLUTIONS INC
bidder
SYNGENE
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite